Intermittent fasting: What questions should we be asking?

Physiol Behav. 2020 May 1:218:112827. doi: 10.1016/j.physbeh.2020.112827. Epub 2020 Feb 1.

Abstract

Obesity and overweight are contributing factors to chronic disease. Lifestyle management, which incorporates advice on moderate daily caloric restriction (CR) and physical activity to reduce body weight, is the cornerstone treatment in practice. Intermittent fasting (IF) is a popular alternative that cycles fasting with unrestricted eating periods. IF appears to be an equivalent approach to CR to induce weight loss, although as yet there is limited long-term evidence. Some controversy exists as to whether IF yields superior health benefits to CR. Discrepancies between studies may be due to the heterogeneity in the design of IF protocols. There is also still some concerns around the safety and feasibility of IF compared to CR, which has not been well-studied to date. Moreover, the underlying cellular pathways that are differentially activated in IF in comparison to CR requires further investigation in humans. This review summarises trials that have compared IF with CR, and discusses evidence from animal studies to raise questions for future research in humans.

Keywords: Daily calorie restriction; Energy metabolism; Intermittent fasting; Meal timing; Metabolic adaptation; Treatment outcome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Caloric Restriction*
  • Fasting*
  • Humans
  • Obesity / therapy
  • Overweight
  • Weight Loss